TRCT
ITRM

Tower Research Capital (TRC)’s Iterum Therapeutics ITRM Stock Holding History

Tower Research Capital (TRC)’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-710
Closed -$1.26K – 5494
2024
Q4 		$1.26K Buy
+710
New +$1.11K ﹤0.01% 5058
2024
Q3 		– Sell
-100
Closed -$114 – 5847
2024
Q2 		$114 Sell
100
-368
-79% -$533 ﹤0.01% 5475
2024
Q1 		$721 Buy
+468
New +$761 ﹤0.01% 5396
2023
Q4 		– Sell
-22
Closed -$18 – 6050
2023
Q3 		$18 Sell
22
-10
-31% -$9 ﹤0.01% 5838
2023
Q2 		$34 Sell
32
-9,636
-100% -$10.7K ﹤0.01% 5892
2023
Q1 		$10K Buy
9,668
+5,267
+120% +$6.07K ﹤0.01% 4359
2022
Q4 		$4K Buy
4,401
+3,079
+233% +$4.38K ﹤0.01% 5022
2022
Q3 		$2K Buy
+1,322
New +$4.01K ﹤0.01% 5569
2022
Q1 		– Sell
-1,811
Closed -$11K – 6317
2021
Q4 		$11K Buy
+1,811
New +$14K ﹤0.01% 4422
2021
Q3 		– Sell
-7,759
Closed -$269K – 5954
2021
Q2 		$269K Buy
7,759
+7,753
+129,217% +$168K 0.01% 1693
2021
Q1 		$0 Buy
+6
New +$143 ﹤0.01% 5545
2019
Q4 		– Hold
0
– – – 3930
2019
Q3 		– Sell
-65
Closed -$6.33K – 4302
2019
Q2 		$7K Buy
65
+7
+12% +$778 ﹤0.01% 2766
2019
Q1 		$7K Buy
58
+10
+21% +$917 ﹤0.01% 2872
2018
Q4 		$4K Sell
48
-161
-77% -$15.2K ﹤0.01% 3041
2018
Q3 		$21K Buy
209
+204
+4,080% +$26.6K ﹤0.01% 2315
2018
Q2 		$1K Buy
+5
New +$903 ﹤0.01% 3488

Other funds holding ITRM

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Tower Research Capital (TRC)'s ITRM Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Iterum Therapeutics (ITRM) in Q1 2025, closing a stake of 710 shares — an estimated $1.26K sold.

Tower Research Capital (TRC) first reported a position in ITRM in Q2 2018 and held it in 16 quarters. The position peaked at $269K in Q2 2021. 20 funds tracked by Wall St. Rank hold ITRM as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Iterum Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 710 Iterum Therapeutics shares in Q1 2025, an estimated $1.26K.
  • Tower Research Capital (TRC) first reported a position in Iterum Therapeutics in Q2 2018 and held it in 16 quarters.
  • Tower Research Capital (TRC)'s Iterum Therapeutics position peaked at $269K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.